MPT0L145 is a PIK3C3/FGFR3 inhibitor which simultaneously promotes autophagosome formation via FGFR3 inhibition and impairs autophagy flux via PIK3C3 inhibition in bladder cancer cells with FGFR3 activation [25,30]. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.